Amarin Corp Plc (AMRN)

[caddiedad]

Thanks LBL for this repost.
“These areas of investigation include cancer, inflammatory bowel disease, infections, Alzheimer’s disease, dementia, and depression. The next decade promises to deepen our understanding of the beneficial effects that EPA may offer beyond cardiovascular risk reduction.”

This agent is readily available for use and has a good safety profile, making it a favourable agent to consider for AD prevention. Currently, Carlsson et al. are conducting a small randomized clinical trial to determine if EPA beneficially affects cerebrovascular function or cognitive performance in cognitively healthy adults at increased risk for AD called Brain Amyloid and Vascular Effects of Eicosapentaenoic Acid (BRAVE-EPA)

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7537800/